[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fvbJIJNuHEaOHrSz0pUbiGamQBuzZ6KLbDXoDplNLesc":8,"$fTSz9_glWG4X-lRFimBPdWFcI4QtvEOg1bGiNkSii93g":15,"$fO7PAAe-t3dDrausFzO64Rbmhe-B85Z4zDxZUjNsHJ5c":21},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":14},200,"操作成功",{"authors":12,"appraiseDimensionScoresVos":13},[],[],true,{"code":9,"msg":10,"message":6,"data":16,"success":14},{"pageNo":17,"pageSize":18,"result":19,"totalSize":20},1,10,[],0,{"code":9,"msg":10,"message":6,"data":22,"success":14},{"id":23,"specialistId":24,"specialistAssistants":25,"profilePhoto":26,"specialistName":27,"hospital":28,"department":29,"postsTitle":30,"materialTotal":31,"videoTotal":20,"isConcern":7,"title":32,"coverVertical":33,"coverAcross":34,"content":35,"description":36,"views":37,"likes":20,"isThumbsUp":7,"isCollection":7,"collections":20,"createTime":38,"seoTitle":32,"seoKeywords":39,"seoDescription":40,"shelvesTime":41,"version":31,"menus":42,"menuId":44,"type":17,"quality":61,"commentCount":20,"isComment":17},86228,1073546,[],"https://ystcdn.venuertc.com/venue/app/51989/2026-09-24/a17541e1-1ba3-4890-bd02-688d3e73fa73.png","王雪","天津东丽驯海医院","药剂科","初级药师",2,"他汀类降脂药物科学选药指南——药剂科专业实用指导","","https://ystcdn.venuertc.com/venue/AI/a7edbfb6-30ac-4db5-ba70-1463b1fe4807.jpg","\u003Cdiv class=\"statin-article-container\">\n  \u003Ch1 id=\"material_title\" class=\"statin-title\">\n    他汀类降脂药物科学选药指南——药剂科专业实用指导\n  \u003C/h1>\n  \u003Cdiv class=\"statin-intro statin-bglight\">\n    \u003Cp>\n      他汀类药物是临床上降脂、预防心血管疾病的中坚力量。充分了解他汀类降脂药如何科学选择，可以大幅提升治疗效果、减少不良反应。本文将结合药剂科实践，详细讲解他汀选药的关键要点，为医护人员与患者提供实用、科学的选药方案。\n    \u003C/p>\n    \u003Cp>\n      \u003Cspan class=\"statin-icon\">🩺\u003C/span>\n      \u003Cstrong>他汀核心作用：\u003C/strong>\n      降低总胆固醇、低密度脂蛋白胆固醇（LDL-C，首要靶点），轻度降低甘油三酯并提升高密度脂蛋白（HDL-C）。实用选药时应重点考虑：降脂强度、心血管风险分层、肝肾功能、药物相互作用、不良反应与患者年龄等因素。\n    \u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"statin-section statin-bgtopic1\">\n    \u003Ch2>一、按降脂强度分类（同等剂量下，LDL降幅）\u003C/h2>\n    \u003Cp>\n      基线LDL越高，降脂药物的绝对降幅越大，因此剂量和人群的选择非常重要。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>1. 低强度他汀（LDL-C降幅20%~30%）\u003C/strong>\u003Cbr>\n        \u003Cspan class=\"statin-point\">辛伐他汀10mg、普伐他汀10~20mg、洛伐他汀20mg\u003C/span>\u003Cbr>\n        \u003Cspan class=\"statin-tag\">适用：\u003C/span>低危人群、老年人初始用药、仅轻度胆固醇升高者\u003Cbr>\n        \u003Cspan class=\"statin-tips\">✅特点：\u003C/span>代谢途径简单，药物相互作用极少。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>2. 中等强度他汀（LDL-C降30%~50%，国内首选起始）\u003C/strong>\u003Cbr>\n        \u003Cspan class=\"statin-point\">阿托伐他汀10~20mg、瑞舒伐他汀5~10mg、辛伐他汀20~40mg、普伐他汀40mg、氟伐他汀40~80mg\u003C/span>\u003Cbr>\n        \u003Cspan class=\"statin-tag\">适用：\u003C/span>大多数高血压/冠心病一级预防、稳定期冠心病或脑梗患者。\u003Cbr>\n        \u003Cspan class=\"statin-tips statin-highlight\">中国人群不推荐高强度起始，建议中等强度起始，减少肌病及肝酶升高风险。\u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>3. 高强度他汀（LDL-C降幅≥50%）\u003C/strong>\u003Cbr>\n        \u003Cspan class=\"statin-point\">阿托伐他汀40~80mg、瑞舒伐他汀20~40mg\u003C/span>\u003Cbr>\n        \u003Cspan class=\"statin-tag\">适用：\u003C/span>急性冠脉综合征、心梗、极高危心血管患者\u003Cbr>\n        \u003Cspan class=\"statin-tips statin-warn\">⚠️中国人耐受性较差，不良反应风险升高，可用中等强度+依折麦布替代。\u003C/span>\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\n  \u003Cdiv class=\"statin-section statin-bgtopic2\">\n    \u003Ch2>二、各类他汀药物的特点对比 \u003Cspan class=\"statin-icon\">🔍\u003C/span>\u003C/h2>\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>1. 瑞舒伐他汀\u003C/strong>\u003Cbr>\n        \u003Cspan class=\"statin-detail\">强效，肝肾双通道排泄，肾功能不全需慎用（重度肾衰应减量或避免），药物相互作用较少。\u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>2. 阿托伐他汀\u003C/strong>\u003Cbr>\n        \u003Cspan class=\"statin-detail\">强效，主要肝脏代谢，肾功能障碍者也可安全使用。经CYP3A4代谢，与多种药物有相互作用（如红霉素、克拉霉素、某些抗真菌及钙通道阻滞剂）。\u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>3. 普伐他汀\u003C/strong>\u003Cbr>\n        \u003Cspan class=\"statin-detail\">中低强度，不经CYP450代谢，药物相互作用最少。尤适老年人及多药合用者。水溶性，对肌肉和肝脏更安全。\u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>4. 氟伐他汀\u003C/strong>\u003Cbr>\n        \u003Cspan class=\"statin-detail\">中强度，经CYP2C9代谢，药物相互作用较少。适合不能耐受其他他汀者。\u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>5. 辛伐他汀\u003C/strong>\u003Cbr>\n        \u003Cspan class=\"statin-detail\">性价比高，但CYP3A4代谢，药物相互作用风险高，大剂量时肌病风险增加。\u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>6. 匹伐他汀\u003C/strong>\u003Cbr>\n        \u003Cspan class=\"statin-detail\">中强度，对血糖影响较小，适合合并糖尿病风险的人群，降脂强度偏弱。\u003C/span>\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"statin-tips statin-bgkey\">\n      \u003Cspan>🔥小贴士：\u003C/span>\n      匹伐他汀和普伐他汀对新发糖尿病的风险最低，阿托伐他汀、瑞舒伐他汀风险相对更高，但总体获益远大于风险。极高危人群不可因担心糖尿病而拒绝使用他汀。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"statin-section statin-bgtopic3\">\n    \u003Ch2>三、根据患者情况科学选药\u003C/h2>\n    \u003Col>\n      \u003Cli>\n        \u003Cstrong>1. 心血管危险分层（决定目标LDL，再选强度）\u003C/strong>\n        \u003Cul>\n          \u003Cli>\n            \u003Cspan class=\"statin-badge\">极高危\u003C/span>（如心梗、脑梗、ACS、冠脉支架、外周动脉病）：LDL-C目标＜1.4mmol/L；首选中高强度他汀，用药不达标可加依折麦布/PCSK9抑制剂。\n          \u003C/li>\n          \u003Cli>\n            \u003Cspan class=\"statin-badge\">高危\u003C/span> LDL＜1.8mmol/L；可选中等强度他汀起始。\n          \u003C/li>\n          \u003Cli>\n            \u003Cspan class=\"statin-badge\">中低危\u003C/span> LDL＜2.6mmol/L；优先选低至中等强度他汀。\n          \u003C/li>\n        \u003C/ul>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>2. 合并疾病时的选药原则\u003C/strong>\n        \u003Cul>\n          \u003Cli>\n            \u003Cspan class=\"statin-badge statin-bggray\">肾功能不全：\u003C/span> 轻中度肾衰选阿托伐他汀，瑞舒伐他汀需减量，重度CKD忌瑞舒伐他汀、辛伐他汀。\n          \u003C/li>\n          \u003Cli>\n            \u003Cspan class=\"statin-badge statin-bggray\">肝功能异常：\u003C/span>非活动性脂肪肝（转氨酶<3倍上限）可选中等强度他汀，定期复查；活动性肝病/持续转氨酶升高禁用。\n          \u003C/li>\n          \u003Cli>\n            \u003Cspan class=\"statin-badge statin-bggray\">多药同服：\u003C/span>老年人、服用抗感染或抗真菌药者优先普伐他汀、匹伐他汀，避开辛伐他汀、阿托伐他汀。\n          \u003C/li>\n          \u003Cli>\n            \u003Cspan class=\"statin-badge statin-bggray\">他汀肌痛病史：\u003C/span>推荐普伐他汀、氟伐他汀，对症调整剂量或间断用药。\n          \u003C/li>\n          \u003Cli>\n            \u003Cspan class=\"statin-badge statin-bggray\">糖尿病或代谢综合征：\u003C/span>首选匹伐他汀；必要时极高危患者可用阿托伐他汀或瑞舒伐他汀，并加强血糖监测。\n          \u003C/li>\n        \u003C/ul>\n      \u003C/li>\n    \u003C/ol>\n  \u003C/div>\n\n  \u003Cdiv class=\"statin-section statin-bgtopic4\">\n    \u003Ch2>四、不良反应监测要点 \u003Cspan class=\"statin-icon\">⚠️\u003C/span>\u003C/h2>\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>1. 肌肉损害：\u003C/strong>表现为肌痛、肌炎、严重者可致横纹肌溶解。大剂量、高龄、肾功能不全或合用CYP3A4抑制剂更高风险。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>2. 肝脏不良反应：\u003C/strong>用药前查肝功能，用药后若肝酶升高>3倍上限，需停药并及时评估。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>3. 血糖变化：\u003C/strong>他汀或可轻度升高血糖，增加新发糖尿病风险。建议治疗期间监测空腹血糖和糖化血红蛋白。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\n  \u003Cdiv class=\"statin-section statin-bgtopic5\">\n    \u003Ch2>五、通用他汀用药原则\u003C/h2>\n    \u003Col>\n      \u003Cli>\n        中国人群不推荐常规高强度起始，首选中等强度。血脂未达标时优先联合降脂药，而非盲目加大他汀剂量。\n      \u003C/li>\n      \u003Cli>\n        半衰期短的如辛伐他汀、普伐他汀、氟伐他汀建议晚上服用；阿托伐他汀、瑞舒伐他汀、匹伐他汀半衰期长，一天任何时间均可。\n      \u003C/li>\n      \u003Cli>\n        启动他汀治疗前应查血脂、肝功能、肌酸激酶CK、肾功能；用药4~6周后复查血脂、肝酶、CK；血脂达标后建议半年至一年复查一次。\n      \u003C/li>\n    \u003C/ol>\n  \u003C/div>\n\n  \u003Cdiv class=\"statin-section statin-bgtopic6\">\n    \u003Ch2>六、简单选药口诀\u003Cspan class=\"statin-icon\">📒\u003C/span>\u003C/h2>\n    \u003Cdiv class=\"statin-poem\">\n      极高危要强效，阿托瑞舒来担当；\u003Cbr>\n      多病多药老年者，普伐他汀更稳当；\u003Cbr>\n      肾不好选阿托，肾衰慎用瑞舒伐；\u003Cbr>\n      担心血糖往上跑，匹伐他汀可考量；\u003Cbr>\n      国人起始中强度，不达标优先联合。\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\u003Cstyle>\n.statin-article-container {\n  max-width: 900px;\n  margin: 32px auto 32px auto;\n  font-family: 'Segoe UI', 'Arial', sans-serif;\n  background-color: #f8f9fa;\n  padding: 40px 30px 30px 30px;\n  border-radius: 18px;\n  box-shadow: 0 6px 28px rgba(80,110,175,0.1);\n}\n.statin-title {\n  font-size: 2.3em;\n  text-align: center;\n  color: #2b3c4b;\n  font-weight: 700;\n  letter-spacing: 1px;\n  margin-bottom: 32px;\n  padding-top: 8px;\n  padding-bottom: 8px;\n}\n.statin-icon {\n  font-size: 1.15em;\n}\n.statin-intro {\n  font-size: 1.08em;\n  background: linear-gradient(90deg,#e8f0fe 0%,#d1f2eb 100%);\n  border-radius: 11px;\n  padding: 18px 18px 11px 18px;\n  margin-bottom: 28px;\n  border-left:5px solid #2692f3;\n}\n.statin-section {\n  background: #fff;\n  padding: 22px 16px 18px 20px;\n  border-radius: 11px;\n  margin-bottom: 24px;\n  box-shadow: 0 2px 8px rgba(120,160,200,0.08);\n}\n.statin-bglight {\n  background: linear-gradient(90deg, #e3f2fd 30%, #fff 100%);\n}\n.statin-bgtopic1 {\n  background: repeating-linear-gradient(-45deg, #e8f6fd, #e8f6fd 18px, #fafdfe 18px, #fafdfe 40px);\n}\n.statin-bgtopic2 {\n  background: repeating-linear-gradient(-20deg, #f7f2fa, #f7f2fa 22px, #fdfafd 22px, #fdfafd 44px);\n}\n.statin-bgtopic3 {\n  background: repeating-linear-gradient(5deg, #f9fbe7, #f9fbe7 15px, #f5fdeb 15px, #f5fdeb 36px);\n}\n.statin-bgtopic4 {\n  background: repeating-linear-gradient(120deg, #fbeee6, #fbeee6 18px, #fff 18px, #fff 40px);\n}\n.statin-bgtopic5 {\n  background: repeating-linear-gradient(-30deg, #efefef, #efefef 26px, #f7eeed 26px, #f7eeed 52px);\n}\n.statin-bgtopic6 {\n  background: repeating-linear-gradient(15deg, #eff4fa, #fff 18px, #fff 18px, #eff4fa 36px);\n}\n.statin-point {\n  color: #0e71b2;\n  font-weight: 500;\n}\n.statin-tips {\n  display: block;\n  margin-top: 3px;\n  margin-bottom: 6px;\n  color: #05797a;\n  font-size: 0.97em;\n}\n.statin-tag {\n  color: #9f6900;\n  font-weight: 600;\n}\n.statin-tips.statin-highlight {\n  color: #d93232;\n}\n.statin-tips.statin-warn {\n  color: #c75016;\n  font-weight: bold;\n}\n.statin-detail {\n  color: #444970;\n  font-size: 1.08em;\n}\n.statin-bgkey {\n  background: #f4f5e6;\n  color: #8e561a;\n  border-radius: 7px;\n  padding: 9px 11px;\n  margin: 12px 4px 4px 4px;\n  font-size: 1.04em;\n}\n.statin-badge {\n  background: #c1e7fa;\n  color: #2256b7;\n  border-radius: 4px;\n  padding: 2px 7px;\n  margin-right: 4px;\n  font-size: 0.99em;\n  display: inline-block;\n}\n.statin-badge.statin-bggray {\n  background: #ecedee;\n  color: #8a5b2d;\n}\n.statin-poem {\n  background: #eef9fa;\n  color: #195b7c;\n  font-size: 1.09em;\n  padding: 16px 14px 12px 19px;\n  border-left: 5px solid #27b4c9;\n  border-radius: 7px;\n  margin-top: 12px;\n  line-height: 1.9em;\n  font-family: 'Microsoft YaHei', 'Helvetica', sans-serif;\n  box-shadow: 0 1px 6px rgba(34,140,210,0.06);\n}\n@media (max-width:680px) {\n  .statin-title { font-size: 1.33em; }\n  .statin-article-container { padding: 10px 3% 10px 3%; }\n  .statin-section { padding-left: 6px; padding-right: 5px;}\n}\n\u003C/style>","\u003Cdiv class=\"statin-article-container\">\n  \u003Ch1 id=\"material_title\" class=\"statin-title\">\n    他汀类降脂药物科学",978,"2026-09-28 15:02:22","他汀类药物, 降脂, 心血管疾病, 药物相互作用, 不良反应","详细讲解他汀类降脂药物的科学选药要点，帮助医护人员和患者提高治疗效果，减少不良反应，适合预防心血管疾病的最佳方案。","2026-09-28 19:42:00",[43],{"menuId":44,"menuName":45,"parentId":20,"orderNum":31,"path":46,"component":47,"isFrame":48,"isCache":49,"menuType":50,"visible":17,"status":20,"createDept":6,"remark":33,"createTime":51,"children":52,"columnImage":53,"columnLogo":54,"uncheckedLogo":6,"checkedLogo":6,"isHot":17,"isHome":20,"forceLogin":20,"color":55,"seoTitle":56,"seoKeywords":57,"seoDescription":58,"contentNum":6,"promotionalPoster":59,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":60,"routerPath":46,"componentInfo":47},"1986713082609147906","健康科普","article","/article.html","1","0","T","2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","慢性病,重大疾病"]